Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Improves Hunger and Satiety, Leading to Weight Loss in Overweight/Obese Adults

被引：0

|

作者：

Day, Wesley W.

Najarian, Thomas

Troupin, Barbara

Tam, Peter

Peterson, Craig

机构：

来源：

OBESITY | 2010年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S154 / S154

页数：1

相关论文

共 43 条

[1] Long-term glycaemic effects of weight loss with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR) in overweight/obese subjects with diabetes
Van Gaal, L. F.
Cheskin, L. J.
Najarian, T.
Day, W. W.
Peterson, C. A.
DIABETOLOGIA, 2011, 54 : S371 - S371
[2] Improvements in Quality of Life (QoL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) in Overweight/Obese Subjects
Kolotkin, Ronette L.
Peterson, Craig
Gadde, Kishore M.
OBESITY, 2010, 18 : S155 - S155
[3] Weight Loss (WL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Correlates With Improvements in Liver Function in Overweight/Obese Adults With Elevated Alanine Aminotransferase (ALT)
Klein, Samuel
Najarian, Thomas
Troupin, Barbara
Day, Wesley W.
OBESITY, 2011, 19 : S177 - S177
[4] Changes in Insulin Sensitivity in Overweight/Obese Patients Treated with Low-Dose, Controlled-Release Phentermine/Topiramate(PHEN/TPM)
Garvey, W. Timothy
Gadde, Kishore
Tam, Peter
Peterson, Craig
DIABETES, 2010, 59 : A481 - A481
[5] LOW-DOSE CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE (PHEN/TPM CR) RESULTS IN SIGNIFICANT WEIGHT LOSS AND IMPROVES ATHEROSCLEROTIC BIOMARKERS IN OVERWEIGHT/OBESE PATIENTS WITH OBESITY-RELATED COMORBIDITIES.
Troupin, B.
Hankin, C. S.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S39 - S39
[6] Severely Obese Adults Administered Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Maintained Their Weight Loss in the Second Year
Gadde, Kishore M.
Allison, David B.
Tam, Peter
Troupin, Barbara
OBESITY, 2011, 19 : S176 - S176
[7] Long-Term Weight Loss and Improvement in Glycemic Parameters with Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR)
Kushner, Robert F.
Garvey, W. Timothy
Troupin, Barbara
Day, Wesley W.
DIABETES, 2011, 60 : A515 - A515
[8] Low-Dose, Controlled-Release Phentermine/Topiramate (PHEM/TPM CR) Reduces Adiposity, Improves Cardiometabolic Risk in Overweight/Obese Patients
Gallagher, Dympna
Punyanitya, Mark
Bowden, Charles
Peterson, Craig
OBESITY, 2010, 18 : S154 - S154
[9] Weight Loss With Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Improves Plasma Alanine Transaminase (ALT) Concentrations
Klein, Samuel
Najarian, Thomas
Day, Wesley W.
OBESITY, 2010, 18 : S155 - S155
[10] Amount of cardiometabolic risk reduction is directly associated with magnitude of weight loss with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR)
Klein, S.
Tam, P.
Peterson, C.
DIABETES OBESITY & METABOLISM, 2010, 12 : 52 - 52

← 1 2 3 4 5 →